X

Lidocaine Patch: A Topical Analgesic for Treatment for Postherpetic Neuralgia

By: Irene Li, PharmD Candidate c/o 2016 - Postherpetic neuralgia is the most common chronic complication of herpes zoster that…

eMAR

Stem Cells May Halt Progression of Multiple Sclerosis

By: Nehali Parikh, PharmD Candidate c/o 2016 - Multiple sclerosis (MS) is an autoimmune disease that results in interrupted neurotransmission…

eMAR

Miltefosine (Impavido®) Approved to Treat Tropical Disease

By: Sang Hyo Kim, Staff Editor - On March 19, 2014, the U.S Food and Drug Administration (FDA) approved miltefosine…

eMAR

Meet Corlanor®: A New Drug for Chronic Heart Failure

By: Svetlana Akbasheva, Staff Editor - For years, the medications that have been the mainstay of therapy for chronic heart…

eMAR

FDA Approves Vorapaxar

By: Azia Tariq, Section Editor - Myocardial infarctions, more commonly known as heart attacks, are prevalent in the United States.…

eMAR

Treatment Options for Restless Legs Syndrome

By: Svetlana Akbasheva, Staff Editor -       Restless Legs Syndrome (RLS or Willis-Ekbom disease) is a condition that affects an…

eMAR

Illegal Sale of Drugs Online

By: Benedette Cuffari, BS Toxicology Candidate, ‘16 - “Initial Prescription Free,” “FDA Approved,”  “Save Thousands!” and “Our Generic Drugs are…

eMAR

A Link Between Genetics and the Treatment Prognosis of Depression

By: Jacqueline Meaney, PharmD [PGY-1 Resident at Gainesville VAMC in Florida] - Major depressive disorder (MDD) is a psychiatric disorder…

eMAR

Pharmaceutical Fellowship Tips

By: Sean Caltabiano, Ramya Mathew & Praneeta Nagraj - Timeline Overview 5th Year: Start thinking about recommendations Your preceptors on…

eMAR

When Technology and Medicine Unite

By: Tyler Valente, PharmD Candidate c/o 2016 - A growing trend within our progressive society is the advancement of technology.…

eMAR